haemoptysis and/or bacterial pneumonia. Case 1: a 71-year-old male with multiple cavitary lesions and emphysema. He received three courses of therapy: one for 5 months, one for a month, and one for a month and half. Pericavitary infiltrates and wall thickening were improved on chest imaging, and his weight and serous albumin levels increased. Case 2: an 82-year-old male with cavities and nodules preceded by severe panlobular emphysema. He received two 1-month treatments and exhibited no significant improvement on radiography. Case 3: a 68-year-old female with cavities and bronchiectasis with consolidation opacities. Instillation was ceased within 2 weeks because of mild bronchial bleeding.
searched. The randomized controlled trials (RCTs) evaluating the effect of TI on bronchiectasis patients were included. Outcome measures included pulmonary function, inflammatory markers, arterial blood gas, clinical effective rate and adverse reactions. Study selection, data extraction and risk of bias assessment were independently undertaken, respectively. Statistical analysis was conducted by RevMan software (version 5.3).
Results: Eleven studies (825 participants) were included. Compared to the control group, effective rate was higher [RR = 1.16, 95%CI
(1.08,1.24); Z = 4.17, P < 0.0001], and pulmonary function improved more in the treatment group, with forced vital capacity (FVC) [MD = 0.45, 95% CI (0.34, 0.56) ; Z = 8.01, P < 0.00001], forced expiratory volume in one second (FEV 1 ) [MD = 0.39, 95% CI (0.24, 0.54) ; Z = 5.06, P < 0.00001], FEV 1 % predicted [MD = 6.35, 95%CI (3.80, 8.90 Conclusion: On the basis of western medicine, TI might enhance clinical efficacy, improve pulmonary function, increase PaO 2 , reduce neutrophils ratio and procalcitonin of bronchiectasis patients, and have no serious adverse reaction. However, the efficacy and safety of TI for bronchiectasis remain to be further verified by high quality multi-center RCTs. Pleural drainage becomes difficult to manage, and surgical intervention is necessary. Thoracoscopic surgery (TS) is now widely performed due to its low invasiveness. However the number of high risk cases with poor PS and complications are increasing in Japan recently. Aim of this study was to review the clinical and surgical outcome of patients who underwent surgery.
Methods: This retrospective study included who underwent surgery for parepneumonic effusion or acute empyema in our department from January 2006 to April 2018 at our institute. Pre-, intra-, and postoperative characteristics were observed.
Results: 1. Preoperative characteristics: Total of 25 patients (male: 22, female: 3) with median age of 64 years (range: 2 to 84). preoperative clinical characteristics in detail were shown in Table. The average period from symptom onset to surgery and from hospital admission to surgery was 6.8 AE 10.5 (1-16) days.
2. Intraoperative characteristics: The operation was accomplished by TS in 23 (92%), and conversion to thoracotomy was in 2 (2%). Cause of
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Division of Nephrology, Chang Gung Memorial Hospital, Linkou branch, Taiwan
Background and Aims: Infectious complication is a serious cause of morbidity and mortality in lung transplantation patients. In this study, we analyzed the pulmonary infection condition and microbiology data in post-lung transplantation patients.
Methods:
We collected all of the lung transplantation patients in Chang Gung Memorial Hospital, Linkou branch since Dec. 2016 to Dec. 2017. All of the patients used prophylaxis antibiotics after the operation including a glycopeptide, a carbapenem, cotrimoxazole, valganciclovir and anidulafungin. The donor lung tissue swab cultures were sent routinely during the transplantation. The sputum cultures were collected according to the clinical suspicious, and the bronchoscopy with bronchoalveolar lavage (BAL) would be arranged routinely.
Results: Total 8 patients had done the bilateral lung transplantation in this period. All of the donor lungs tissue swab cultures were positive that the Klebsiella pneumoniae was the most common bacterial pathogen. However, only 1 patient had the same microbiology result from donor lung tissue swab culture and BAL after the transplantation (both revealed Stenotrophomonas). No patient had positive result of aspergillus, cytomegalovirus, Pneumocystis jiroveci pneumonia or tuberculosis within 1 month post-transplantation. The aspergillus tracheobronchitis was noted in a patient 35 days after transplantation which was confirmed by biopsy pathology. There were 4 patients had positive BAL bacterial culture within 1 week post-operation, and 3 of them were mortality within 6 months post-operation due to different ethology. All other patients who had no positive BAL culture data within 1 week post-operation were survival till now (P = 0.028).
Conclusion:
The prophylaxis antibiotics regimens we used were effective in preventing post-lung transplantation infection from the donor lung or other opportunistic infection. The early positive BAL culture (postlung transplantation within 7 days) may be a predictor for early mortality in lung transplantation patients. Results: Seventy patients were enrolled from four hospitals. Median age was 81 years (range 46-97). There were 38 (54%) males. In comorbidity, 28 (40%) had heart disease, and 23 (33%) had dementia or cerebrovascular disease. Influenza A was 38 cases (52%). Eight cases (11%) died. There was no significant difference in patient background between the deceased and survivors. In post-influenza respiratory complications, 79% of surviving groups had secondary or coexisting bacterial pneumonia, and ARDS was diagnosed in 3 cases (5%). On the other hand, 5 cases (62%) had secondary or coexisting bacterial pneumonia and 3 cases (38%) had ARDS in the deceased group. Sputum culture revealed that S. aureus was the most frequent and found in 11 cases (16%), and all cases survived. Gram-negative bacilli were found in 14 cases (20%), and 4 of them (29%) died.
The post-influenza respiratory complications that require hospitalization are frequent among elderly people with underlying diseases, and the mortality rate was as high as 11%. Attention should be paid because of the high mortality rate when gram negative bacilli infection is combined. account for 4 million deaths annually and together are the leading cause of mortality in children ≤5 years. Understanding prescribing patterns of antimicrobials for LRTIs is important in optimizing antimicrobial use, especially given increasing antimicrobial resistance globally. We investigated
